Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine

Catheterization and Cardiovascular Interventions

Volumn 59, Issue 3, 2003, Pages 338-343

  Lindsay, Joseph ^a   Apple, Sue ^a   Pinnow, Ellen E ^a   Gevorkian, Natalie ^a   Gruberg, Luis ^b   Satler, Lowell F ^a   Pichard, Augusto D ^a   Kent, Kenneth M ^a   Suddath, William ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Nephropathy; Outcome; Percutaneous coronary intervention

Indexed keywords

CREATININE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAUCASIAN; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL CIRCULATION; PREDICTION; RETROSPECTIVE STUDY; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY STENOSIS; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROBABILITY; REFERENCE VALUES; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0038692923     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10534     Document Type: Article

References (15)

1. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375.
2. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. Arch Intern Med 1990;150:1237-1541.
3. Gruberg L, Mintz GS, Mehran R, Dangas G, Lansky AJ, Kent KM, Pichard AD, Leon MB. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542-1548.
4. Weisberg LS, Kurnik PB, Kurnik BRC. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994;45:259-265.
5. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol 2000;11:177-182.
6. Parfrey PS, Griffiths SM, Barrett BJ, Genge PM, Withers J, Farid N, McManamon PJ. Contrast-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med 1989;320:143-149.
7. Barrett BJ. Contrast nephrotoxicity, J Am Soc Nephrol 1994;5:125-137.
8. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
9. Carrie BJ, Golbetz HV, Michaels AS, Myers BD. Creatinine: an inadequate filtration marker in glomerular diseases. Am J Med 1980;69:177-182.
10. Hall WD. Abnormalities of kidney function as a cause and a consequence of cardiovascular disease. Am J Med Sci 1999;317:176-182.
11. Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S, for the HOPE investigators. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001;134:629-636.
12. Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol 2001;38:1782-1787.
13. Rubenstein MH, Harrell LC, Sheynberg BV, Schunkert H, Bazari H, Palacios IF. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 2000;102:2966-2972.
14. Gruberg L, Weissman NJ, Waksman R, Laird JR Jr, Pinnow EE, Wu H, Dieble R, Kent KM, Pichard AD, Satler LF, Lindsay J Jr. Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild renal insufficiency. Am J Cardiol 2002;89:54-57.
15. Rubenstein MH, Sheynberg BV, Harrell LC, Schunkert H, Bazari H, Palacios IF. Effectiveness and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol 2001;87:856-860.